JACOBS LEVY EQUITY MANAGEMENT, INC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 182 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$25,159,662
-39.3%
1,122,698
+10.2%
0.15%
-37.7%
Q2 2023$41,429,472
+18.3%
1,018,674
+40.9%
0.24%
+11.2%
Q1 2023$35,015,968
+4.1%
722,873
-18.0%
0.22%
-5.7%
Q4 2022$33,641,359
+21.2%
881,356
+59.4%
0.23%
+4.1%
Q3 2022$27,754,000
-15.7%
552,863
-32.7%
0.22%
-14.1%
Q2 2022$32,933,000
+39.4%
822,094
+29.9%
0.26%
+60.4%
Q1 2022$23,618,000
+2.4%
633,030
+9.3%
0.16%
+3.2%
Q4 2021$23,070,000
+43.9%
579,216
+34.5%
0.15%
+42.6%
Q3 2021$16,028,000
-11.4%
430,757
+0.6%
0.11%
-12.2%
Q2 2021$18,099,000
+177.0%
428,173
+210.3%
0.12%
+146.0%
Q1 2021$6,534,000
+133.4%
137,984
+200.7%
0.05%
+100.0%
Q4 2020$2,800,000
+24.9%
45,885
-4.3%
0.02%
+8.7%
Q3 2020$2,241,000
-15.7%
47,945
-8.5%
0.02%
-20.7%
Q2 2020$2,659,000
+113.4%
52,396
+87.6%
0.03%
+81.2%
Q1 2020$1,246,000
+311.2%
27,926
+342.6%
0.02%
+433.3%
Q4 2019$303,000
+37.7%
6,310
-3.1%
0.00%0.0%
Q3 2019$220,000
-2.2%
6,510
+29.9%
0.00%0.0%
Q2 2019$225,000
-62.4%
5,010
-60.7%
0.00%
-62.5%
Q3 2018$599,000
+27.7%
12,740
-8.3%
0.01%
+14.3%
Q2 2018$469,000
+136.9%
13,900
+17.3%
0.01%
+133.3%
Q4 2017$198,000
-19.8%
11,850
-52.7%
0.00%
-40.0%
Q1 2017$247,000
-21.3%
25,060
-12.9%
0.01%
-16.7%
Q4 2016$314,00028,7700.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Burrage Capital Management LLC 161,083$9,831,0007.49%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 333,000$20,323,0005.55%
RTW INVESTMENTS, LP 4,221,836$257,659,0004.32%
GEORGE KAISER FAMILY FOUNDATION 90,011$10,766,0002.85%
SECTORAL ASSET MANAGEMENT INC 603,978$36,861,0002.60%
Redwood Investments, LLC 364,837$22,266,0001.90%
ARMISTICE CAPITAL, LLC 716,000$43,697,0001.49%
CM Management, LLC 25,000$1,526,0001.42%
Third Security, LLC 237,015$14,465,0001.32%
Sofinnova Investments, Inc. 316,478$19,315,0001.15%
View complete list of PTC THERAPEUTICS INC shareholders